Abstract: A system and method therein for assigning environmental impact values to mass excavation projects utilizing an excavation site is described. The method comprise obtaining a daily operating time of one or more loading assets at the excavation site, determining at least one first environmental impact based on the obtained daily operating time and at least one fuel or energy consumption rate, obtaining a distance to a target depositing site for one or more transporting assets, determining at least one second environmental impact based on the obtained distances and at least one fuel or energy consumption rate, and assigning at least part of the determined first and second environmental impact to one or more of the mass excavation projects.

Abstract: A system includes a transmitter configured to emit a signal. The system includes a control system, configured to determine a geographical mitigation region of a satellite, determine the transmitter is located within the geographical mitigation region, and modify an operation of the transmitter to mitigate interference with an observation sensing activity of the satellite.

Abstract: Systems and methods for selective modification of nanoparticle structures are described. The selective modification processes include applying a localized heat source to the deposited nanoparticle structures and removing the areas that are not activated by the localized heat.

Abstract: A system and method for automatically adjusting one or more parameters of a header of an agricultural harvester for gathering a crop and feeding the crop into a feeder housing includes receiving, from one or more sensors, a signal indicative of a position of a conveyor idler of a conveyor of the feeder housing over time. The system and method also includes providing one or more control signals to adjust the one or more parameters of the header based on variation of the position of the conveyor idler over time.

Abstract: The present disclosure provides compositions and in vitro or ex vivo methods for obtaining an enhanced antigen specific Th1 immune response. The compositions can comprise activation enhanced dendritic cells or T cells produced in vitro. The methods comprise contacting immature dendritic cells with a maturation agent that comprises a dendritic cell maturation agent, interferon ? and an inflammation-activating lipid which can produced hyperactivated dendritic cells. The method can further comprise contacting the maturing dendritic cells with a predetermined antigen during maturation. An in vitro or ex vivo method is also provided wherein the hyperactive dendritic cells can be used to induce naive T cell activation, where the activated T cells can be formulated for administration to an individual in need of such treatment.

Abstract: Disclosed is a method for determining one or more tractor units for a tractor-trailer in a system including a plurality of electrically driven tractor units. Each tractor unit is configured to form a tractor-trailer with a respective trailer and to tow the respective trailer. The method includes: receiving a first item of transport order information, representing a loading position and an unloading position, receiving first items of tractor unit information representing a current position of the respective tractor unit and an estimated current range of the respective tractor unit, determining the first tractor unit in order to form a first tractor-trailer for transporting the goods along a first section of a transport route, the determination of the first tractor unit being performed while considering the first item of transport order information and the first items of tractor unit information.

Abstract: A trailer, in particular a utility trailer, for road vehicles on which an extendable current collector or an electrical contact element for an inverted current collector is placed.

Abstract: Provided herein are HLA-PEPTIDE targets and antigen binding proteins that bind HLA-PEPTIDE targets. Also disclosed are methods for identifying the HLA-PEPTIDE targets as well as identifying one or more antigen binding proteins that bind a give n HLA-PEPTIDE target.

Abstract: Systems of electrical devices with high-resolution components and methods of fabricating the electrical devices using micro-molding processes are described. Small foot print electrical devices can be achieved by fabricating components with highly conductive materials, and with closely spaced components.

Abstract: The present invention it was determined that dendritic cells could be derived from various sources including peripheral blood monocytes in the presence of only GM-CSF without other cytokines if the monocytes were not activated. By preventing activation, such as by preventing binding of the cells to the surface of the culture vessel, the monocytes do not require the presence of additional cytokines, such as IL-4 or IL-13, to prevent differentiation into a non-dendritic cell lineage. The immature DCs generated and maintained in this manner were CD14? and expressed high levels of CD1a. Upon maturation by contact with an agent such as, for example, BCG and IFN?, the cells were determined to express surface molecules typical of mature dendritic cells purified by prior methods and cultured in the presence of GM-CSF and IL-4.

Abstract: In connection with an RF communication system, exemplary aspects involve a method for use in a communication system in which a first system (e.g., 802.11) that is asynchronously based and which is susceptible to interference from a second system (e.g., synchronous-based LTE-CV2X). Such interference is due to the frequency spectrum used by the first and second systems overlapping. To mitigate interference issues, example methods spreads out the times for messages in the first system, based on information concerning occupancy of the channel, and transmitting them relative to the end of a cycled transmission allocated for use by the second system.

Abstract: This disclosure relates to a transgenic plant or plant tissue. In particular, this disclosure relates to a transgenic plant or plant tissue or plant cell comprising at least one polynucleotide comprising at least one sequence encoding a variable domain of a heavy-chain antibody (VHH) specifically binding to a sphingolipid of a fungus. Advantageously, the expression of the polynucleotide in at least part of the transgenic plant or plant tissue or plant cell (i) protects at least part of the transgenic plant or plant tissue or plant cell from an infection with a plant pathogenic fungus, (ii) inhibits the growth of a plant pathogenic fungus on at least part of the transgenic plant or plant tissue or plant cell, or (iii) increases the resistance of at least part of the transgenic plant or plant tissue or plant cell against a plant pathogenic fungus.

Abstract: A composition for the treatment of Demodex blepharitis and/or acne containing tea tree oil (TTO), coconut oil, aloe barbadensis, decyl glucoside, sodium chloride, sodium lauroyl methyl isethionate, Caprylic/Capric Triglyceride, Caprylyl Glycol, Ethylhexylglycerin, and Hexylene Glycol in glycerin or in water or in a mixture of glycerin and water. The composition is used to treat Demodex blepharitis and/or acne by applying the composition to the eyelid margin and eyelashes or acne and scrubbing the eyelid margin, eyelashes, and eyelash roots or acne with the composition using any suitable cloth, wipe, sponge, brush, or cotton tipped applicator.

Abstract: The present invention relates to the use of substituted indole derivatives and substituted indoline derivatives in the manufacture of a medicament for the treatment of dengue disease in an individual infected by dengue virus or the prevention of dengue disease in an individual at risk of being infected by Dengue virus. The invention further provides a method for the treatment or the prevention of dengue in an individual at risk of being infected by Dengue virus.

Abstract: A method for fixing and treating a flexible plate on a drum includes: providing a flexible plate comprising a support layer made of a first material and at least one additional layer made of a second material which is different from the first material, wherein one or more thin film side wings are connected to one or more sides of the flexible plate. The one or more thin film side wings have a thickness which is at least 5 times smaller than the thickness of the flexible plate. The method further includes positioning the flexible plate on the drum such that the lower face of each thin film side wing of the flexible plate covers at least one vacuum suction opening, and performing a treatment on at least one layer of the flexible plate while rotating the drum.

Abstract: An original text that is a representation of a narration of a patient encounter provided by a clinician may be received and re-formatted to produce a formatted text. One or more clinical facts may be extracted from the formatted text. A first fact of the clinical facts may be extracted from a first portion of the formatted text, and the first portion of the formatted text may be a formatted version of a first portion of the original text. A linkage may be maintained between the first fact and the first portion of the original text.

Abstract: Provided herein are HLA-PEPTIDE targets and antigen binding proteins that bind HLA-PEPTIDE targets. Also disclosed are methods for identifying the HLA-PEPTIDE targets as well as identifying one or more antigen binding proteins that bind a given HLA-PEPTIDE target.

Abstract: Provided herein are HLA-PEPTIDE targets and multispecific antigen binding proteins that bind HLA-PEPTIDE targets. Provided herein is an isolated multispecific antigen binding protein (ABP), comprising: a first antigen binding domain (ABD) that specifically binds to a human leukocyte antigen (HLA)-PEPTIDE target; and an additional ABD that specifically binds an additional antigen, wherein the HLA-PEPTIDE target comprises an HLA-restricted peptide complexed with an HLA Class I molecule, wherein the HLA-restricted peptide is located in the peptide binding groove of an ?1/?2 heterodimer portion of the HLA Class I molecule, and wherein the HLA-PEPTIDE target is selected from Table A, Table A1, or Table A2.

Abstract: An Enhancement Mode (e-mode) Metal Insulator Semiconductor (MIS) High Electron Mobility Transistor (HEMT), or EMISHEMT, with GaN channel regrowth under a gate area, is described. The EMISHEMT with GaN channel regrowth under a gate area provides a normally-off device with a suitably high and stable threshold voltage, while providing a low gate leakage current. A channel layer provides a 2DEG and associated low on-resistance, while a channel-material layer extends through an etched recess and into the channel layer, and disrupts the 2DEG locally to enable the normally-off operation.

Abstract: The present disclosure provides populations of cells comprising partially mature and optimally activated dendritic cells that can be used for administration to individuals having a cancer and/or tumor. Partially matured dendritic cells, those contacted with a dendritic cell maturation agent for about 10 to about 19 hours, upon administration efficiently take up and process tumor antigens in the area of the tumor site, complete maturation, and can subsequently migrate to the lymph nodes of a treated individual. Once in a lymph node the now fully mature antigen presenting dendritic cells secrete the appropriate cytokines (e.g., TNF?, IL-6, IL-8, and/or IL-12) and contact T cells inducing a substantial and optimal clinical and/or anti-tumor immune response.